mTOR Inhibitor Immunosuppressant [EPC]

mTOR Inhibitor Immunosuppressant [EPC] was reported 63135 times

These side effects are most commonly reported by patients taking drugs of the mTOR Inhibitor Immunosuppressant [EPC] class:

# Drug class Count
0 DEATH 6689
1 MALIGNANT NEOPLASM PROGRESSION 4801
2 DIARRHOEA 4641
3 FATIGUE 4107
4 OFF LABEL USE 4008
5 DRUG INEFFECTIVE 3509
6 STOMATITIS 3387
7 NAUSEA 3182
8 DYSPNOEA 2874
9 PYREXIA 2703
10 VOMITING 2397
11 DECREASED APPETITE 2246
12 PNEUMONIA 2207
13 RASH 2151
14 WEIGHT DECREASED 2108
15 ASTHENIA 2067
16 COUGH 2060
17 MALAISE 1963
18 PRODUCT USE IN UNAPPROVED INDICATION 1958
19 DISEASE PROGRESSION 1805
20 PAIN 1735
21 ANAEMIA 1675
22 HEADACHE 1580
23 ABDOMINAL PAIN 1343
24 PNEUMONITIS 1307
25 METASTASES TO LIVER 1302
26 PLEURAL EFFUSION 1234
27 DEHYDRATION 1193
28 HYPERTENSION 1177
29 ACUTE KIDNEY INJURY 1169
30 OEDEMA PERIPHERAL 1141
31 GENERAL PHYSICAL HEALTH DETERIORATION 1134
32 DRUG INTERACTION 1129
33 BLOOD PRESSURE INCREASED 1074
34 METASTASES TO BONE 1073
35 NEOPLASM PROGRESSION 1059
36 THROMBOCYTOPENIA 1056
37 DIZZINESS 1025
38 RENAL IMPAIRMENT 1015
39 ARTHRALGIA 1012
40 PRURITUS 1002
41 BLOOD CREATININE INCREASED 962
42 PERIPHERAL SWELLING 958
43 NEUTROPENIA 933
44 HAEMOGLOBIN DECREASED 917
45 BACK PAIN 905
46 TOXICITY TO VARIOUS AGENTS 903
47 ABDOMINAL PAIN UPPER 899
48 CONSTIPATION 899
49 MUCOSAL INFLAMMATION 883
50 URINARY TRACT INFECTION 876
51 INFECTION 872
52 PAIN IN EXTREMITY 860
53 RENAL FAILURE 857
54 PLATELET COUNT DECREASED 855
55 INTERSTITIAL LUNG DISEASE 848
56 BLOOD GLUCOSE INCREASED 846
57 EPISTAXIS 816
58 MOUTH ULCERATION 810
59 SEPSIS 808
60 NEOPLASM MALIGNANT 805
61 ORAL PAIN 787
62 SEIZURE 754
63 METASTASES TO LUNG 735
64 BREAST CANCER METASTATIC 730
65 TRANSPLANT REJECTION 713
66 DRUG INTOLERANCE 712
67 BREAST CANCER 694
68 CYTOMEGALOVIRUS INFECTION 675
69 CONDITION AGGRAVATED 674
70 RESPIRATORY FAILURE 673
71 THROMBOTIC MICROANGIOPATHY 657
72 PRODUCT USE ISSUE 652
73 FALL 650
74 CHEST PAIN 649
75 HYPERGLYCAEMIA 644
76 COVID-19 615
77 HYPOTENSION 609
78 ABDOMINAL DISCOMFORT 584
79 ASCITES 584
80 NASOPHARYNGITIS 584
81 DIABETES MELLITUS 579
82 LUNG DISORDER 578
83 ERYTHEMA 577
84 INSOMNIA 543
85 ACNE 532
86 LEUKOPENIA 526
87 DRY SKIN 524
88 BLOOD CHOLESTEROL INCREASED 516
89 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 507
90 WHITE BLOOD CELL COUNT DECREASED 502
91 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 495
92 SEPTIC SHOCK 486
93 ABDOMINAL DISTENSION 484
94 GAIT DISTURBANCE 481
95 PULMONARY EMBOLISM 481
96 DYSGEUSIA 474
97 FEELING ABNORMAL 472
98 OEDEMA 466
99 PANCYTOPENIA 463
100 CHILLS 462
101 MULTIPLE ORGAN DYSFUNCTION SYNDROME 461
102 ALOPECIA 460
103 CONFUSIONAL STATE 457
104 BK VIRUS INFECTION 454
105 DYSPHAGIA 452
106 MYALGIA 447
107 OROPHARYNGEAL PAIN 440
108 BONE PAIN 432
109 CARDIAC FAILURE 431
110 ANXIETY 428
111 OSTEONECROSIS OF JAW 427
112 FEBRILE NEUTROPENIA 421
113 INFLUENZA 419
114 C-REACTIVE PROTEIN INCREASED 416
115 PROTEINURIA 414
116 PULMONARY OEDEMA 399
117 EPSTEIN-BARR VIRUS INFECTION 396
118 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 394
119 DRY MOUTH 385
120 ALANINE AMINOTRANSFERASE INCREASED 376
121 ASPARTATE AMINOTRANSFERASE INCREASED 373
122 WEIGHT INCREASED 365
123 HYPERSENSITIVITY 361
124 METASTASES TO LYMPH NODES 353
125 PRODUCT DOSE OMISSION ISSUE 353
126 HOSPITALISATION 349
127 JOINT SWELLING 349
128 PERICARDIAL EFFUSION 343
129 SOMNOLENCE 339
130 HYPOKALAEMIA 338
131 APHTHOUS ULCER 333
132 DRUG LEVEL INCREASED 333
133 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 333
134 SWELLING 332
135 HEPATIC ENZYME INCREASED 329
136 RENAL DISORDER 324
137 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 321
138 DEPRESSION 320
139 NEUROPATHY PERIPHERAL 320
140 TREMOR 320
141 BLOOD PRESSURE SYSTOLIC INCREASED 319
142 EATING DISORDER 316
143 GASTROINTESTINAL HAEMORRHAGE 315
144 INFLAMMATION 311
145 DRUG RESISTANCE 310
146 METASTASES TO CENTRAL NERVOUS SYSTEM 306
147 HYPOXIA 305
148 CHRONIC KIDNEY DISEASE 304
149 TREATMENT FAILURE 304
150 DYSPHONIA 299
151 THROMBOSIS 299
152 MUSCLE SPASMS 297
153 GASTROINTESTINAL DISORDER 296
154 KIDNEY TRANSPLANT REJECTION 296
155 THERAPY NON-RESPONDER 296
156 ILLNESS 295
157 HYPOPHAGIA 288
158 NEPHROPATHY TOXIC 288
159 BLOOD TRIGLYCERIDES INCREASED 287
160 HYPOAESTHESIA 287
161 GAMMA-GLUTAMYLTRANSFERASE INCREASED 286
162 LYMPHADENOPATHY 284
163 SINUSITIS 284
164 URTICARIA 280
165 CELLULITIS 279
166 HEART RATE INCREASED 274
167 FLUSHING 273
168 PARAESTHESIA 273
169 HAEMORRHAGE 272
170 FLATULENCE 270
171 IMPAIRED HEALING 270
172 THERAPY CESSATION 270
173 PRODUCTIVE COUGH 269
174 TUMOUR MARKER INCREASED 268
175 CHRONIC GRAFT VERSUS HOST DISEASE 265
176 LIVER DISORDER 265
177 THERAPY INTERRUPTED 263
178 BLISTER 262
179 CEREBROVASCULAR ACCIDENT 262
180 LETHARGY 261
181 MUSCULOSKELETAL PAIN 261
182 CONTUSION 259
183 BLOOD ALKALINE PHOSPHATASE INCREASED 258
184 BLOOD LACTATE DEHYDROGENASE INCREASED 258
185 HYPERTRIGLYCERIDAEMIA 258
186 LUNG INFILTRATION 256
187 BLOOD PRESSURE DECREASED 253
188 CYTOMEGALOVIRUS INFECTION REACTIVATION 250
189 PNEUMOCYSTIS JIROVECII PNEUMONIA 250
190 MUSCULAR WEAKNESS 249
191 SECOND PRIMARY MALIGNANCY 248
192 DYSPNOEA EXERTIONAL 246
193 MYOCARDIAL INFARCTION 246
194 LOSS OF CONSCIOUSNESS 245
195 FEEDING DISORDER 244
196 HEPATIC FUNCTION ABNORMAL 244
197 COLITIS 243
198 DRUG LEVEL DECREASED 243
199 INTESTINAL OBSTRUCTION 243
200 SWELLING FACE 243
201 INJECTION SITE PAIN 242
202 RHINORRHOEA 242
203 POLYOMAVIRUS VIRAEMIA 241
204 GRAFT VERSUS HOST DISEASE 240
205 RENAL FAILURE ACUTE 238
206 TACHYCARDIA 238
207 NEOPLASM 236
208 DEEP VEIN THROMBOSIS 235
209 CHEST DISCOMFORT 233
210 MEMORY IMPAIRMENT 233
211 METASTASIS 232
212 ANGIOEDEMA 231
213 ATRIAL FIBRILLATION 230
214 DRUG HYPERSENSITIVITY 229
215 DYSPEPSIA 227
216 HERPES ZOSTER 227
217 NEUROENDOCRINE TUMOUR 227
218 SKIN EXFOLIATION 227
219 HYPONATRAEMIA 226
220 BACTERIAL INFECTION 225
221 VIRAL INFECTION 225
222 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 223
223 HEPATIC FAILURE 222
224 HYPOGLYCAEMIA 220
225 SYNCOPE 220
226 THERAPY PARTIAL RESPONDER 219
227 ACUTE GRAFT VERSUS HOST DISEASE 217
228 HEPATIC LESION 217
229 RED BLOOD CELL COUNT DECREASED 217
230 NEUTROPHIL COUNT DECREASED 211
231 SKIN LESION 210
232 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 207
233 METASTASES TO SPINE 207
234 UPPER RESPIRATORY TRACT INFECTION 207
235 HYPERLIPIDAEMIA 206
236 LYMPHOCYTE COUNT DECREASED 205
237 FLUID RETENTION 203
238 BLOOD UREA INCREASED 201
239 CYTOMEGALOVIRUS VIRAEMIA 200
240 INCORRECT DOSE ADMINISTERED 199
241 PULMONARY MASS 199
242 BRONCHITIS 198
243 BLOOD POTASSIUM DECREASED 197
244 SQUAMOUS CELL CARCINOMA OF SKIN 197
245 STAPHYLOCOCCAL INFECTION 197
246 DYSURIA 196
247 KAPOSI^S SARCOMA 195
248 RENAL CELL CARCINOMA 193
249 ADENOVIRUS INFECTION 191
250 NO ADVERSE EVENT 191
251 GLOSSODYNIA 190
252 RESPIRATORY DISTRESS 190
253 VISUAL IMPAIRMENT 190
254 TRANSAMINASES INCREASED 189
255 BRONCHOPULMONARY ASPERGILLOSIS 188
256 CARDIAC FAILURE CONGESTIVE 188
257 DISEASE RECURRENCE 188
258 ACUTE RESPIRATORY DISTRESS SYNDROME 185
259 RASH PRURITIC 185
260 LYMPHOPENIA 184
261 GASTRITIS 183
262 HOT FLUSH 183
263 PNEUMOTHORAX 183
264 BODY TEMPERATURE DECREASED 181
265 LYMPHOEDEMA 181
266 PANCREATITIS 181
267 CARDIAC ARREST 180
268 CHOLELITHIASIS 180
269 THERAPEUTIC RESPONSE DECREASED 180
270 PANCREATIC NEUROENDOCRINE TUMOUR 177
271 HAEMOPTYSIS 176
272 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 176
273 SKIN DISORDER 176
274 SKIN ULCER 176
275 CARDIAC DISORDER 173
276 HYPERHIDROSIS 173
277 HAEMATOCRIT DECREASED 172
278 PALPITATIONS 172
279 FUNGAL INFECTION 170
280 LIVER TRANSPLANT REJECTION 170
281 RHABDOMYOLYSIS 170
282 TASTE DISORDER 170
283 BONE MARROW FAILURE 169
284 HAEMATURIA 169
285 PULMONARY TOXICITY 169
286 JAUNDICE 168
287 LIVER FUNCTION TEST ABNORMAL 168
288 NEEDLE ISSUE 168
289 RENAL CANCER 168
290 RENAL TUBULAR NECROSIS 168
291 VIRAEMIA 168
292 SPEECH DISORDER 167
293 HYPERCHOLESTEROLAEMIA 166
294 HYPOTHYROIDISM 166
295 ORAL HERPES 166
296 PSEUDOMONAS INFECTION 164
297 ACUTE RESPIRATORY FAILURE 163
298 ESCHERICHIA INFECTION 162
299 GASTROOESOPHAGEAL REFLUX DISEASE 162
300 INFLUENZA LIKE ILLNESS 162
301 SKIN DISCOLOURATION 162
302 SLEEP DISORDER 161
303 AGEUSIA 159
304 LUNG INFECTION 159
305 VISION BLURRED 159
306 NASAL CONGESTION 158
307 HYPERKALAEMIA 157
308 CLOSTRIDIUM DIFFICILE INFECTION 156
309 EPILEPSY 154
310 INTENTIONAL PRODUCT USE ISSUE 154
311 BLOOD GLUCOSE DECREASED 153
312 OXYGEN SATURATION DECREASED 153
313 RESPIRATORY TRACT INFECTION 152
314 BLOOD BILIRUBIN INCREASED 151
315 CANDIDA INFECTION 150
316 METABOLIC ACIDOSIS 150
317 COMPLICATIONS OF TRANSPLANTED KIDNEY 147
318 HAEMATOCHEZIA 147
319 ABNORMAL BEHAVIOUR 146
320 HYPOACUSIS 146
321 STRESS 146
322 MULTI-ORGAN FAILURE 145
323 HYPOCALCAEMIA 144
324 METASTATIC RENAL CELL CARCINOMA 144
325 POLLAKIURIA 144
326 SWOLLEN TONGUE 144
327 NAIL DISORDER 143
328 ADVERSE DRUG REACTION 142
329 BURNING SENSATION 142
330 HEPATITIS 141
331 GLOMERULAR FILTRATION RATE DECREASED 140
332 MIGRAINE 140
333 GASTROENTERITIS 138
334 MENTAL STATUS CHANGES 138
335 PAIN IN JAW 138
336 KIDNEY FIBROSIS 137
337 WHEEZING 137
338 WHITE BLOOD CELL COUNT INCREASED 137
339 CHOLANGITIS 136
340 GRAFT VERSUS HOST DISEASE IN SKIN 136
341 HYPERCALCAEMIA 136
342 METASTASES TO SKIN 136
343 ORAL MUCOSAL BLISTERING 136
344 CYSTITIS 135
345 MUSCULOSKELETAL CHEST PAIN 135
346 SQUAMOUS CELL CARCINOMA 134
347 CONCOMITANT DISEASE AGGRAVATED 132
348 CYTOPENIA 132
349 CHOLESTASIS 131
350 DISCOMFORT 131
351 SPINAL PAIN 131
352 TRANSPLANT FAILURE 131
353 HEPATOTOXICITY 130
354 BLOOD SODIUM DECREASED 129
355 LIP SWELLING 128
356 NERVOUSNESS 128
357 EAR INFECTION 127
358 ENCEPHALOPATHY 127
359 HYPOPHOSPHATAEMIA 127
360 RESPIRATORY DISORDER 127
361 TOOTHACHE 127
362 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 126
363 MYELOSUPPRESSION 126
364 BLOOD POTASSIUM INCREASED 125
365 GASTROENTERITIS VIRAL 125
366 BALANCE DISORDER 124
367 GENERALISED OEDEMA 124
368 KLEBSIELLA INFECTION 124
369 NECK PAIN 124
370 PNEUMONIA BACTERIAL 124
371 ATELECTASIS 123
372 BODY TEMPERATURE INCREASED 122
373 ULCER 122
374 METASTASES TO PERITONEUM 120
375 AGITATION 119
376 CATARACT 119
377 LIVER FUNCTION TEST INCREASED 119
378 ASTHMA 118
379 BONE LESION 118
380 HYDRONEPHROSIS 118
381 MOVEMENT DISORDER 118
382 ONYCHOCLASIS 118
383 AGGRESSION 117
384 BLOOD URINE PRESENT 116
385 COVID-19 PNEUMONIA 116
386 MELAENA 115
387 WOUND 115
388 BASAL CELL CARCINOMA 114
389 DERMATITIS 114
390 CONVULSION 113
391 HEART RATE DECREASED 113
392 ASPERGILLUS INFECTION 111
393 FAECES DISCOLOURED 111
394 INJECTION SITE MASS 111
395 LOWER RESPIRATORY TRACT INFECTION 111
396 NIGHT SWEATS 111
397 EXPOSURE DURING PREGNANCY 110
398 HAEMATEMESIS 110
399 MASS 110
400 RASH GENERALISED 110
401 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 109
402 CEREBRAL HAEMORRHAGE 109
403 HEPATIC NEOPLASM 109
404 MALNUTRITION 109
405 CACHEXIA 108
406 DRY EYE 108
407 ENTEROCOCCAL INFECTION 108
408 ORGANISING PNEUMONIA 108
409 DISORIENTATION 107
410 DYSLIPIDAEMIA 107
411 GASTRIC ULCER 107
412 HAEMATOMA 107
413 ORAL DISCOMFORT 107
414 POLYNEUROPATHY 107
415 AMNESIA 106
416 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 106
417 METASTASES TO PLEURA 106
418 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 106
419 EJECTION FRACTION DECREASED 105
420 ILL-DEFINED DISORDER 104
421 OSTEONECROSIS 104
422 MOBILITY DECREASED 103
423 SMOOTH MUSCLE CELL NEOPLASM 103
424 BLOOD ALBUMIN DECREASED 102
425 CHRONIC ALLOGRAFT NEPHROPATHY 102
426 DEPRESSED MOOD 102
427 DRUG-INDUCED LIVER INJURY 102
428 ELECTROLYTE IMBALANCE 102
429 FEELING HOT 102
430 HYPOGAMMAGLOBULINAEMIA 102
431 COMA 101
432 OSTEOPOROSIS 101
433 PERITONITIS 101
434 ECZEMA 100
435 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 100
436 EYE SWELLING 100
437 HEART TRANSPLANT REJECTION 100
438 HEPATITIS E 100
439 IRRITABILITY 100
440 NEPHROLITHIASIS 100
441 PULMONARY FIBROSIS 100
442 SMALL INTESTINAL OBSTRUCTION 100
443 URINE OUTPUT DECREASED 100
444 UROSEPSIS 100
445 ARRHYTHMIA 99
446 BLOOD CALCIUM DECREASED 99
447 CYTOMEGALOVIRUS COLITIS 99
448 HAEMORRHOIDS 99
449 ORAL DISORDER 99
450 OVERDOSE 99
451 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 98
452 PYELONEPHRITIS 98
453 RASH ERYTHEMATOUS 98
454 VERTIGO 98
455 FEELING COLD 97
456 FREQUENT BOWEL MOVEMENTS 97
457 HAEMATOTOXICITY 97
458 ILEUS 97
459 LUNG NEOPLASM MALIGNANT 97
460 RECTAL HAEMORRHAGE 97
461 BACTERAEMIA 96
462 BLOOD GLUCOSE ABNORMAL 96
463 GINGIVAL PAIN 96
464 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 96
465 ODYNOPHAGIA 96
466 APHASIA 95
467 BREAST CANCER RECURRENT 95
468 COAGULOPATHY 95
469 NEUROTOXICITY 95
470 SKIN CANCER 95
471 TUBULOINTERSTITIAL NEPHRITIS 94
472 CARDIO-RESPIRATORY ARREST 93
473 HEPATOMEGALY 93
474 PALLOR 93
475 TENDERNESS 93
476 NODULE 92
477 PRODUCT DOSE OMISSION 92
478 CHOLECYSTITIS 91
479 CONCOMITANT DISEASE PROGRESSION 91
480 HERPES SIMPLEX 91
481 ABDOMINAL PAIN LOWER 90
482 ADVERSE EVENT 90
483 BLOOD PRESSURE DIASTOLIC DECREASED 90
484 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 90
485 HYPOALBUMINAEMIA 90
486 IMMUNOSUPPRESSION 90
487 LEUKOCYTOSIS 90
488 PULMONARY CONGESTION 90
489 DYSSTASIA 89
490 FOETAL EXPOSURE DURING PREGNANCY 89
491 HYPERSOMNIA 89
492 PARVOVIRUS B19 INFECTION 89
493 TOOTH DISORDER 89
494 DECREASED IMMUNE RESPONSIVENESS 88
495 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 88
496 DRUG DOSE OMISSION 87
497 GAIT INABILITY 87
498 OVARIAN CYST 87
499 BONE DISORDER 86
500 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 86
501 ENTERITIS 86
502 EPSTEIN-BARR VIRAEMIA 86
503 NEPHROTIC SYNDROME 86
504 PNEUMONIA ASPIRATION 86
505 ARTHRITIS 85
506 BLOOD CREATINE PHOSPHOKINASE INCREASED 85
507 BLOOD MAGNESIUM DECREASED 85
508 FULL BLOOD COUNT DECREASED 85
509 HEPATOCELLULAR CARCINOMA 85
510 HYPOMAGNESAEMIA 85
511 IMMUNODEFICIENCY 85
512 NERVOUS SYSTEM DISORDER 85
513 OESOPHAGITIS 85
514 RECURRENT CANCER 85
515 TYPE 2 DIABETES MELLITUS 85
516 ACUTE MYOCARDIAL INFARCTION 84
517 BLOOD PRESSURE FLUCTUATION 84
518 FACE OEDEMA 84
519 BLOOD PRESSURE ABNORMAL 83
520 BRAIN NEOPLASM 83
521 DIFFUSE LARGE B-CELL LYMPHOMA 83
522 HEPATIC CIRRHOSIS 83
523 CLOSTRIDIUM DIFFICILE COLITIS 82
524 DELIRIUM 82
525 PLATELET COUNT INCREASED 82
526 ANGINA PECTORIS 81
527 MEDICATION ERROR 81
528 TACHYPNOEA 81
529 THERAPY CHANGE 81
530 DRUG LEVEL BELOW THERAPEUTIC 80
531 HEMIPARESIS 80
532 MATERNAL EXPOSURE DURING PREGNANCY 80
533 PHARYNGITIS 80
534 COGNITIVE DISORDER 79
535 PRURITUS GENERALISED 79
536 PULMONARY HYPERTENSION 79
537 SHOCK 79
538 URINARY RETENTION 79
539 HUMAN POLYOMAVIRUS INFECTION 78
540 NEPHROPATHY 78
541 PANCREATITIS ACUTE 78
542 PNEUMONIA CYTOMEGALOVIRAL 78
543 RESPIRATORY ARREST 78
544 SKIN TOXICITY 78
545 ACUTE MYELOID LEUKAEMIA 77
546 CARDIOMYOPATHY 77
547 ENCEPHALITIS 77
548 GENERALISED TONIC-CLONIC SEIZURE 77
549 HEPATIC CANCER 77
550 INTESTINAL PERFORATION 77
551 LUNG CONSOLIDATION 77
552 MITRAL VALVE INCOMPETENCE 77
553 OSTEOMYELITIS 77
554 SURGERY 77
555 DERMATITIS ACNEIFORM 76
556 DEVICE RELATED INFECTION 76
557 EYELID OEDEMA 76
558 GLYCOSYLATED HAEMOGLOBIN INCREASED 76
559 LUNG TRANSPLANT REJECTION 76
560 LYMPHANGIOSIS CARCINOMATOSA 76
561 LYMPHOCELE 76
562 RALES 76
563 TRANSPLANT DYSFUNCTION 76
564 TREATMENT NONCOMPLIANCE 76
565 BLOOD CHROMOGRANIN A INCREASED 75
566 EAR PAIN 75
567 END STAGE RENAL DISEASE 75
568 LABORATORY TEST ABNORMAL 75
569 ORAL CANDIDIASIS 75
570 CROHN^S DISEASE 74
571 ELECTROCARDIOGRAM QT PROLONGED 74
572 HOSPICE CARE 74
573 OCULAR HYPERAEMIA 74
574 SKIN INFECTION 74
575 DIVERTICULITIS 73
576 GOUT 73
577 HUMAN HERPESVIRUS 8 INFECTION 73
578 LIMB DISCOMFORT 73
579 OSTEOARTHRITIS 73
580 PULMONARY HAEMORRHAGE 73
581 ROAD TRAFFIC ACCIDENT 73
582 APLASTIC ANAEMIA 72
583 BACTERIAL SEPSIS 72
584 BRAIN OEDEMA 72
585 CARDIOMEGALY 72
586 DIARRHOEA HAEMORRHAGIC 72
587 HEPATIC STEATOSIS 72
588 KIDNEY INFECTION 72
589 LOCALISED INFECTION 72
590 METASTATIC NEOPLASM 72
591 RENAL TUBULAR ATROPHY 72
592 SHOCK HAEMORRHAGIC 72
593 TOOTH INFECTION 72
594 HEART RATE IRREGULAR 71
595 JC VIRUS INFECTION 71
596 LIVER INJURY 71
597 PIK3CA-ACTIVATED MUTATION 71
598 RETCHING 71
599 UPPER GASTROINTESTINAL HAEMORRHAGE 71
600 URINARY INCONTINENCE 71
601 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 70
602 DRUG LEVEL ABOVE THERAPEUTIC 70
603 FLANK PAIN 70
604 HEPATIC ENCEPHALOPATHY 70
605 LIVER ABSCESS 70
606 RENAL PAIN 70
607 VARICELLA ZOSTER VIRUS INFECTION 70
608 ANURIA 69
609 BLOOD COUNT ABNORMAL 69
610 HUMAN HERPESVIRUS 6 INFECTION 69
611 MUSCULOSKELETAL STIFFNESS 69
612 PATHOGEN RESISTANCE 69
613 TUBERCULOSIS 69
614 VENOOCCLUSIVE LIVER DISEASE 69
615 APHONIA 68
616 APHTHOUS STOMATITIS 68
617 CENTRAL NERVOUS SYSTEM LESION 68
618 HEPATITIS C 68
619 HERNIA 68
620 THROAT IRRITATION 68
621 ABSCESS 67
622 BLOOD CALCIUM INCREASED 67
623 GALLBLADDER DISORDER 67
624 LACRIMATION INCREASED 67
625 MOOD ALTERED 67
626 SKIN MASS 67
627 CARBOHYDRATE ANTIGEN 15-3 INCREASED 66
628 DISSEMINATED INTRAVASCULAR COAGULATION 66
629 ESCHERICHIA URINARY TRACT INFECTION 66
630 LOCAL SWELLING 66
631 PNEUMONIA FUNGAL 66
632 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 66
633 TERMINAL STATE 66
634 TRANSITIONAL CELL CARCINOMA 66
635 ADRENAL INSUFFICIENCY 65
636 BONE CANCER 65
637 CYSTITIS HAEMORRHAGIC 65
638 HIP FRACTURE 65
639 LACTIC ACIDOSIS 65
640 RASH MACULO-PAPULAR 65
641 CEREBRAL INFARCTION 64
642 CORONARY ARTERY DISEASE 64
643 DEPRESSED LEVEL OF CONSCIOUSNESS 64
644 ESCHERICHIA SEPSIS 64
645 EYE DISORDER 64
646 GINGIVITIS 64
647 HALLUCINATION 64
648 RENAL CYST 64
649 RIB FRACTURE 64
650 SKIN IRRITATION 64
651 TUMOUR PAIN 64
652 ACUTE HEPATIC FAILURE 63
653 BLINDNESS 63
654 CHEILITIS 63
655 DIABETES MELLITUS INADEQUATE CONTROL 63
656 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 63
657 HEPATOCELLULAR INJURY 63
658 LUNG NEOPLASM 63
659 MENSTRUATION IRREGULAR 63
660 PULMONARY ALVEOLAR HAEMORRHAGE 63
661 TONGUE ULCERATION 63
662 BREAST PAIN 62
663 DYSARTHRIA 62
664 HAEMOLYTIC URAEMIC SYNDROME 62
665 HEPATIC PAIN 62
666 JOINT INJURY 62
667 ATAXIA 61
668 BLOOD IRON DECREASED 61
669 CONJUNCTIVITIS 61
670 GASTRIC DISORDER 61
671 HEPATITIS B 61
672 MYELODYSPLASTIC SYNDROME 61
673 NOCARDIOSIS 61
674 POLYURIA 61
675 SINUS TACHYCARDIA 61
676 BOWEL MOVEMENT IRREGULARITY 60
677 CARDIOVASCULAR DISORDER 60
678 EYE PAIN 60
679 HEAD INJURY 60
680 INVASIVE DUCTAL BREAST CARCINOMA 60
681 METASTASES TO ADRENALS 60
682 PELVIC PAIN 60
683 PERIPHERAL COLDNESS 60
684 PNEUMOCYSTIS JIROVECII INFECTION 60
685 ACTINIC KERATOSIS 59
686 MALIGNANT PLEURAL EFFUSION 59
687 NECROSIS 59
688 PROSTATE CANCER 59
689 RENAL TRANSPLANT FAILURE 59
690 RENAL TUBULAR INJURY 59
691 STATUS EPILEPTICUS 59
692 ANAPHYLACTIC REACTION 58
693 BOWEN^S DISEASE 58
694 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 58
695 CREPITATIONS 58
696 ABASIA 57
697 APLASIA PURE RED CELL 57
698 HYPERBILIRUBINAEMIA 57
699 MALIGNANT MELANOMA 57
700 AMENORRHOEA 56
701 DIPLOPIA 56
702 GINGIVAL BLEEDING 56
703 LARGE INTESTINE PERFORATION 56
704 LYMPHADENOPATHY MEDIASTINAL 56
705 NEUTROPHIL COUNT INCREASED 56
706 PATHOLOGICAL FRACTURE 56
707 CHOKING 55
708 CIRCULATORY COLLAPSE 55
709 DIABETIC KETOACIDOSIS 55
710 FAILURE TO THRIVE 55
711 FEMUR FRACTURE 55
712 FURUNCLE 55
713 GASTROINTESTINAL INFECTION 55
714 HAEMOLYSIS 55
715 HYPERVOLAEMIA 55
716 INJECTION SITE SWELLING 55
717 PREMATURE BABY 55
718 RENAL INJURY 55
719 WOUND INFECTION 55
720 BREAST CANCER FEMALE 54
721 CANCER PAIN 54
722 CRYING 54
723 DISTURBANCE IN ATTENTION 54
724 PNEUMATOSIS INTESTINALIS 54
725 PROTEIN TOTAL DECREASED 54
726 BLOOD CREATININE ABNORMAL 53
727 DEAFNESS 53
728 DYSKINESIA 53
729 GASTRIC HAEMORRHAGE 53
730 INCONTINENCE 53
731 INJURY 53
732 IRON DEFICIENCY ANAEMIA 53
733 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 53
734 MOUTH SWELLING 53
735 PRODUCT AVAILABILITY ISSUE 53
736 RETINAL DETACHMENT 53
737 SECRETION DISCHARGE 53
738 SKIN PLAQUE 53
739 SPLENOMEGALY 53
740 BLOOD CREATININE DECREASED 52
741 CYANOSIS 52
742 GINGIVAL SWELLING 52
743 GROIN PAIN 52
744 HEPATIC MASS 52
745 PERFORMANCE STATUS DECREASED 52
746 PHOTOSENSITIVITY REACTION 52
747 PROCTALGIA 52
748 PYELONEPHRITIS ACUTE 52
749 RHINITIS 52
750 THIRST 52
751 TOOTH ABSCESS 52
752 ALVEOLAR PROTEINOSIS 51
753 ARTHROPATHY 51
754 AZOTAEMIA 51
755 DUODENAL ULCER 51
756 FACIAL PARALYSIS 51
757 HYPOKINESIA 51
758 IMMUNE THROMBOCYTOPENIA 51
759 LEFT VENTRICULAR DYSFUNCTION 51
760 LIPASE INCREASED 51
761 MEAN CELL HAEMOGLOBIN DECREASED 51
762 MYOPATHY 51
763 PLASMA CELL MYELOMA 51
764 PROTEIN URINE PRESENT 51
765 RHINOVIRUS INFECTION 51
766 SCLERODERMA 51
767 SNEEZING 51
768 UNRESPONSIVE TO STIMULI 51
769 CHROMATURIA 50
770 HAEMORRHAGE INTRACRANIAL 50
771 INTERNATIONAL NORMALISED RATIO INCREASED 50
772 MENTAL DISORDER 50
773 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 50
774 ARTERIOSCLEROSIS 49
775 BLOOD PHOSPHORUS DECREASED 49
776 EOSINOPHILIA 49
777 OBLITERATIVE BRONCHIOLITIS 49
778 RASH MACULAR 49
779 RESPIRATORY RATE INCREASED 49
780 RESPIRATORY SYNCYTIAL VIRUS INFECTION 49
781 TRICUSPID VALVE INCOMPETENCE 49
782 UNEVALUABLE EVENT 49
783 BRAIN ABSCESS 48
784 CARCINOID TUMOUR 48
785 EMBOLISM 48
786 FLUID OVERLOAD 48
787 GRAFT LOSS 48
788 GRAFT VERSUS HOST DISEASE IN LIVER 48
789 HYPERURICAEMIA 48
790 LIMB INJURY 48
791 MUSCULOSKELETAL DISCOMFORT 48
792 PSYCHOTIC DISORDER 48
793 ABDOMINAL HERNIA 47
794 BLOOD CREATINE INCREASED 47
795 BLOOD THYROID STIMULATING HORMONE INCREASED 47
796 CHAPPED LIPS 47
797 ENTEROCOLITIS 47
798 ERYSIPELAS 47
799 FOLLICULITIS 47
800 GASTROINTESTINAL INFLAMMATION 47
801 MOUTH HAEMORRHAGE 47
802 ORTHOPNOEA 47
803 OSTEOPENIA 47
804 PROCEDURAL PAIN 47
805 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 47
806 PRODUCT QUALITY ISSUE 47
807 PSORIASIS 47
808 ABNORMAL FAECES 46
809 ALTERED STATE OF CONSCIOUSNESS 46
810 BLOOD PRESSURE DIASTOLIC INCREASED 46
811 BRADYCARDIA 46
812 CYTOMEGALOVIRUS TEST POSITIVE 46
813 HYPERTENSIVE CRISIS 46
814 IMMUNE SYSTEM DISORDER 46
815 METASTASES TO THE MEDIASTINUM 46
816 SKIN BURNING SENSATION 46
817 SPINAL COMPRESSION FRACTURE 46
818 SPINAL FRACTURE 46
819 VITAMIN D DECREASED 46
820 ASPHYXIA 45
821 BRONCHIECTASIS 45
822 CARCINOEMBRYONIC ANTIGEN INCREASED 45
823 GENERAL PHYSICAL CONDITION ABNORMAL 45
824 HERPES VIRUS INFECTION 45
825 NEURALGIA 45
826 NO THERAPEUTIC RESPONSE 45
827 PAPULE 45
828 PHARYNGITIS STREPTOCOCCAL 45
829 SUDDEN DEATH 45
830 ASPIRATION 44
831 LOW DENSITY LIPOPROTEIN INCREASED 44
832 METASTASES TO MENINGES 44
833 OLIGURIA 44
834 ONCOLOGIC COMPLICATION 44
835 PIGMENTATION DISORDER 44
836 PNEUMONIA PSEUDOMONAL 44
837 PRODUCT PRESCRIBING ISSUE 44
838 PRODUCT SUBSTITUTION ISSUE 44
839 RED CELL DISTRIBUTION WIDTH INCREASED 44
840 RESTLESSNESS 44
841 THERAPEUTIC RESPONSE UNEXPECTED 44
842 UNDERDOSE 44
843 WOUND DEHISCENCE 44
844 BLOOD TEST ABNORMAL 43
845 ERUCTATION 43
846 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 43
847 FRACTURE 43
848 GASTROINTESTINAL TOXICITY 43
849 HAEMOLYTIC ANAEMIA 43
850 PARONYCHIA 43
851 POOR QUALITY SLEEP 43
852 PORTAL HYPERTENSION 43
853 POST PROCEDURAL COMPLICATION 43
854 REBOUND EFFECT 43
855 RENAL NEOPLASM 43
856 UPPER LIMB FRACTURE 43
857 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 42
858 APHAGIA 42
859 APPENDICITIS 42
860 BILE DUCT STENOSIS 42
861 BLOOD URIC ACID INCREASED 42
862 BREAST MASS 42
863 IGA NEPHROPATHY 42
864 INTUSSUSCEPTION 42
865 ISCHAEMIC STROKE 42
866 RENAL MASS 42
867 SKIN REACTION 42
868 SPUTUM DISCOLOURED 42
869 THYROID DISORDER 42
870 VENOOCCLUSIVE DISEASE 42
871 ANAL INCONTINENCE 41
872 CARDIAC FAILURE ACUTE 41
873 CARDIOGENIC SHOCK 41
874 EYE IRRITATION 41
875 INJECTION SITE INDURATION 41
876 MOOD SWINGS 41
877 MOUTH INJURY 41
878 PANCREATIC CARCINOMA 41
879 PERICARDITIS 41
880 PRODUCT PRESCRIBING ERROR 41
881 RASH PAPULAR 41
882 RASH PUSTULAR 41
883 SKIN NECROSIS 41
884 SUSPECTED OFF LABEL USE 41
885 TUMOUR NECROSIS 41
886 ABORTION SPONTANEOUS 40
887 ACUTE PULMONARY OEDEMA 40
888 DEMENTIA 40
889 EMOTIONAL DISORDER 40
890 ENDOCARDITIS 40
891 HYPERTHYROIDISM 40
892 INGROWING NAIL 40
893 INJECTION SITE ERYTHEMA 40
894 MYCOBACTERIUM HAEMOPHILUM INFECTION 40
895 MYOCLONUS 40
896 NASAL DRYNESS 40
897 NORMOCHROMIC NORMOCYTIC ANAEMIA 40
898 POSTOPERATIVE WOUND INFECTION 40
899 SKIN FISSURES 40
900 TINNITUS 40
901 ACIDOSIS 39
902 ANGER 39
903 CRYPTOSPORIDIOSIS INFECTION 39
904 DENTAL CARIES 39
905 FISTULA 39
906 HEPATIC FIBROSIS 39
907 METABOLIC DISORDER 39
908 MICROSPORIDIA INFECTION 39
909 PHARYNGEAL OEDEMA 39
910 PLEURISY 39
911 PORTAL VEIN THROMBOSIS 39
912 RENAL FAILURE CHRONIC 39
913 SOFT TISSUE INFECTION 39
914 VENOUS THROMBOSIS 39
915 VISUAL ACUITY REDUCED 39
916 AUTOIMMUNE HAEMOLYTIC ANAEMIA 38
917 CARDIOPULMONARY FAILURE 38
918 CHOLECYSTITIS ACUTE 38
919 EXPOSED BONE IN JAW 38
920 FLUID INTAKE REDUCED 38
921 GLOMERULONEPHRITIS 38
922 LIP DRY 38
923 METASTASES TO ABDOMINAL CAVITY 38
924 MYOCARDITIS 38
925 PAPILLOMA VIRAL INFECTION 38
926 PNEUMONIA KLEBSIELLA 38
927 THROMBOTIC THROMBOCYTOPENIC PURPURA 38
928 YELLOW SKIN 38
929 APPETITE DISORDER 37
930 BLOOD GLUCOSE FLUCTUATION 37
931 CORONAVIRUS INFECTION 37
932 CYST 37
933 CYTOMEGALOVIRUS CHORIORETINITIS 37
934 DELAYED GRAFT FUNCTION 37
935 ECCHYMOSIS 37
936 ENTEROBACTER INFECTION 37
937 HYPOAESTHESIA ORAL 37
938 INTENTIONAL PRODUCT MISUSE 37
939 METASTASES TO PANCREAS 37
940 PARTIAL SEIZURES 37
941 PHOTOPHOBIA 37
942 PREMATURE DELIVERY 37
943 TRICHODYSPLASIA SPINULOSA 37
944 URINARY TRACT INFECTION BACTERIAL 37
945 AORTIC VALVE INCOMPETENCE 36
946 BONE MARROW DISORDER 36
947 DEVICE RELATED THROMBOSIS 36
948 ENCEPHALITIS VIRAL 36
949 EOSINOPHIL COUNT INCREASED 36
950 EYE INFECTION 36
951 GASTROENTERITIS NOROVIRUS 36
952 HYPERTRANSAMINASAEMIA 36
953 INFUSION RELATED REACTION 36
954 JAUNDICE CHOLESTATIC 36
955 LINEAR IGA DISEASE 36
956 LOWER LIMB FRACTURE 36
957 METASTASES TO CHEST WALL 36
958 NOROVIRUS INFECTION 36
959 OESOPHAGEAL CANDIDIASIS 36
960 PAIN OF SKIN 36
961 RENAL CANCER METASTATIC 36
962 SEASONAL ALLERGY 36
963 ABDOMINAL ABSCESS 35
964 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 35
965 AGRANULOCYTOSIS 35
966 BILE DUCT OBSTRUCTION 35
967 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35
968 ESCHERICHIA BACTERAEMIA 35
969 GASTROINTESTINAL PAIN 35
970 HEMIPLEGIA 35
971 HEPATIC ENZYME ABNORMAL 35
972 HYPOVOLAEMIC SHOCK 35
973 LYMPHOMA 35
974 NAIL DISCOLOURATION 35
975 NONINFECTIVE GINGIVITIS 35
976 PARALYSIS 35
977 PNEUMONIA VIRAL 35
978 SCAR 35
979 SCIATICA 35
980 SINUS DISORDER 35
981 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 35
982 AMYLASE INCREASED 34
983 CELL MARKER INCREASED 34
984 DIASTOLIC DYSFUNCTION 34
985 DUODENITIS 34
986 FACIAL PAIN 34
987 GASTRIC ANTRAL VASCULAR ECTASIA 34
988 HAEMORRHAGIC STROKE 34
989 HYPOVOLAEMIA 34
990 INJECTION SITE HYPERSENSITIVITY 34
991 INTERNAL HAEMORRHAGE 34
992 LARGE INTESTINAL ULCER 34
993 LIGAMENT SPRAIN 34
994 LIPIDS INCREASED 34
995 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 34
996 MALACOPLAKIA 34
997 MENORRHAGIA 34
998 PRODUCT STORAGE ERROR 34
999 TRANSIENT ISCHAEMIC ATTACK 34